Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/23107
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKızılkaya, Eşref-
dc.date.accessioned2021-12-09T06:46:05Z-
dc.date.available2021-12-09T06:46:05Z-
dc.date.issued2009-04-
dc.identifier.citationGökalp, G. vd. (2009). "Power doppler sonography: Anything to add to BI-RADS US in solid breast masses?". European Journal of Radiology, 70(1), 77-85.en_US
dc.identifier.issn0720-048X-
dc.identifier.urihttps://doi.org/10.1016/j.ejrad.2007.12.007-
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0720048X07006109-
dc.identifier.urihttp://hdl.handle.net/11452/23107-
dc.description.abstractObjective: To evaluate the contribution of power Doppler ultrasonography (PDUS) to breast imaging reporting and data system ultrasonography (BI-RADS US) categorization of solid breast masses. Materials and methods: Totally 94 solid lesions with histopathological results in 49 patients were included in the study. US features of the lesions were classified according to American College of Radiologists (ACR) BI-RADS US lexicon. Lesions were evaluated qualitatively according to their PDUS properties and quantitatively with spectral analysis. Hypervascularity, penetration of vessels into the mass or branching-disordered course and resistivity index values higher than 0.85 were accepted as probable malignant criteria. Results: Fifty-five of 94 lesions were benign (58.5%), while 39 (41.5%) were malignant histopathologically. The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of US and PDUS in the diagnosis of malignant lesions were 100%, 58.2%, 62.9%, 100% and 71.8%, 81.8%, 73.7%, 80.4%, respectively. Criteria used for the distinction of malignant and benign lesions like number of vessels (p < 0.05), distribution of tumoral vessels, morphology of vessels and resistivity index values higher than 0.85 showed statistically significant difference (p < 0.001). When sonographic findings were combined with PDUS and spectral analysis findings, sensitivity, specificity, PPV and NPV were 100%, 52.7%, 60% and 100%, respectively. Conclusion: PDUS and spectral analysis have no contribution to BI-RADS US. For the spectral analysis, when RI value is one or greater, malignancy risk significantly increases.en_US
dc.language.isoenen_US
dc.publisherElsevier Irelanden_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBreasten_US
dc.subjectBI-RADSen_US
dc.subjectPower Doppleren_US
dc.subjectUltrasonographyen_US
dc.subjectColoren_US
dc.subjectLesionsen_US
dc.subjectBenignen_US
dc.subjectVascularityen_US
dc.subjectExperienceen_US
dc.subjectUltrasounden_US
dc.subjectDiagnosisen_US
dc.subjectCanceren_US
dc.subjectTumorsen_US
dc.subjectIndexen_US
dc.subjectRadiology, nuclear medicineen_US
dc.subjectMedical imagingen_US
dc.subjectRisk analysisen_US
dc.subjectSpectrum analysisen_US
dc.subjectSpectrum analyzersen_US
dc.subjectUltrasonographyen_US
dc.subjectBenign lesionsen_US
dc.subjectBI-RADSen_US
dc.subjectBreasten_US
dc.subjectBreast imagingen_US
dc.subjectData systemsen_US
dc.subjectMalignant lesionsen_US
dc.subjectNegative predictive valuesen_US
dc.subjectPositive predictive valuesen_US
dc.subjectPower doppleren_US
dc.subjectPower doppler sonographiesen_US
dc.subjectPower doppler ultrasonographiesen_US
dc.subjectResistivity indicesen_US
dc.subjectSolid breast massen_US
dc.subjectSonographic findingsen_US
dc.subjectSpectral analysisen_US
dc.subjectStatistically significant differencesen_US
dc.subjectUltrasonic imagingen_US
dc.subject.meshAdulten_US
dc.subject.meshAgeden_US
dc.subject.meshAged, 80 and overen_US
dc.subject.meshAlgorithmsen_US
dc.subject.meshBreast neoplasmsen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshImage enhancementen_US
dc.subject.meshImage interpretation, computer-assisteden_US
dc.subject.meshMiddle ageden_US
dc.subject.meshReproducibility of resultsen_US
dc.subject.meshSensitivity and specificityen_US
dc.subject.meshUltrasonography, doppleren_US
dc.subject.meshUltrasonography, mammaryen_US
dc.titlePower doppler sonography: Anything to add to BI-RADS US in solid breast masses?en_US
dc.typeArticleen_US
dc.identifier.wos000265858800013tr_TR
dc.identifier.scopus2-s2.0-63649148417tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Radyoloji Anabilim Dalı.tr_TR
dc.identifier.startpage77tr_TR
dc.identifier.endpage85tr_TR
dc.identifier.volume70tr_TR
dc.identifier.issue1tr_TR
dc.relation.journalEuropean Journal of Radiologyen_US
dc.contributor.buuauthorGökalp, Gökhan-
dc.contributor.buuauthorTopal, Uğur-
dc.contributor.researcheridAAI-2336-2021tr_TR
dc.relation.collaborationYurt içitr_TR
dc.identifier.pubmed18243623tr_TR
dc.subject.wosRadiology, nuclear medicineen_US
dc.subject.wosMedical imagingen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.indexed.pubmedPubmeden_US
dc.wos.quartileQ2en_US
dc.contributor.scopusid8312505100tr_TR
dc.contributor.scopusid57001254100tr_TR
dc.subject.scopusContrast Agent BR1; Breasts; Ultrasonographyen_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeAgeden_US
dc.subject.emtreeApocrine carcinomaen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeBreast canceren_US
dc.subject.emtreeBreast fibroadenomaen_US
dc.subject.emtreeBreast fibrosisen_US
dc.subject.emtreeBreast papillomaen_US
dc.subject.emtreeBreast tumoren_US
dc.subject.emtreeCancer resistanceen_US
dc.subject.emtreeCancer risken_US
dc.subject.emtreeChronic inflammationen_US
dc.subject.emtreeClinical articleen_US
dc.subject.emtreeClinical featureen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeDiagnostic accuracyen_US
dc.subject.emtreeDoppler echographyen_US
dc.subject.emtreeFat necrosisen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeFibrocystic breast diseaseen_US
dc.subject.emtreeHistopathologyen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeHuman tissueen_US
dc.subject.emtreeIntraductal carcinomaen_US
dc.subject.emtreeLung carcinomaen_US
dc.subject.emtreeLymphoid hyperplasiaen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeMastitisen_US
dc.subject.emtreeMedical societyen_US
dc.subject.emtreeMucinous carcinomaen_US
dc.subject.emtreeNeurofibromaen_US
dc.subject.emtreePapillary carcinomaen_US
dc.subject.emtreePrediction and forecastingen_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreeQuantitative analysisen_US
dc.subject.emtreeSpectroscopyen_US
dc.subject.emtreeStatistical significanceen_US
dc.subject.emtreeTumor vascularizationen_US
dc.subject.emtreeUnited Statesen_US
dc.subject.emtreeVascularizationen_US
Appears in Collections:Scopus
Web of Science

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.